Document is current
Any future updates will be listed below
-
Authors
Lehtisalo, Jenni
Sääskilahti, Maria
Härkänen, Tommi
Kulmala, Jenni
Hemiö, Katri
Siltanen, Sini
Zhi, Zhou
Mangialasche, Francesca
Laatikainen, Tiina
Strandberg, Timo
Antikainen, Riitta
Tuomilehto, Jaakko
Soininen, Hilkka
Kivipelto, Miia
Ngandu, Tiia
-
Funding
Funding for this research was provided by:
Ministry of Education and Culture
Finnish Foundation for Cardiovascular Research
State Research Funding of Oulu City Hospital
Kuopio University Hospital
Research Council of Finland
Kela
Juho Vainio Foundation
EU Joint Programme – Neurodegenerative Disease Research
Nordforsk
Alzheimer’s Research and Prevention Foundation
Alzheimerfonden
Swedish Research Council
Center for Innovative Medicine (CIMED) at Karolinska Institutet
Knut and Alice Wallenberg Foundation
Stiftelsen Stockholms Sjukshem
Konung Gustaf V:s och Drottning Victorias Frimurarstiftelse
Region Stockholm ALF
Yrjö Jahnsson Foundation
Swedish Research Council for Health, Working Life and Welfare
Finnish Cultural Foundation
Finnish Institute for Health and Welfare
- License Information
-
More Information
Article History
Received: 13 December 2023
Accepted: 22 April 2025
First Online: 3 May 2025
Declarations
:
: The FINGER trial with extended follow-up and the COVID-19 survey as an amendment to the original protocol were approved by the coordinating ethics committee of the Hospital District of Helsinki and Uusimaa (HUS/1204/2017). Participants gave written informed consents for the original trial and extended follow-up.
: None.
: The authors declare no competing interests.
